Background: Titanium dioxide nanoparticles
(TiO2NPs) are widely utilized and consumed mainly as food
additives.
Oxidative stress is considered to be the basic effect of TiO2NPs through biological interactions. Hesperidin (HSP) is a bioflavonoid
(flavanone glycoside) with lipid-lowering, inflammation, oxidative
stress suppression, antihypertensive, cancer-fighting, and antiedema
effects. Objective: This study was to investigate the
possible protective influences of HSP of subchronic oral TiO2NP exposure on the brains of rats, including neurotransmitters, oxidative
stress/antioxidant parameters, inflammatory markers, and histological
changes in the brains of adult male albino rats. Methodology: The experiment was executed on 80 albino rats. The animals were
randomly divided into 4 equal groups. The first group served as a
control; the second group was treated with oral doses of HSP (100
mg/kg Bw daily); the third group received TiO2NPs (200
mg/kg Bw orally daily); and the fourth group was treated with TiO2NPs and an oral dose of HSP daily for 8 weeks. Blood samples
were obtained for biochemical analysis. Neurotransmitters, oxidative
stress biomarker levels, and inflammatory markers were measured in
brain homogenates. Histological examination of the brain was performed
through H&E staining. Results: Coadministration of
hesperidin with TiO2NPs orally for 8 weeks decreased the
levels of MDA, TNF-α, AChE, and dopamine in brain homogenates,
which were increased in the TiO2NP group. It increased
the other oxidative biomarkers (SOD, CAT, and GPx) and Nrf-2 expression
levels. Brain histological sections of the TiO2NP-treated
group show degeneration, necrosis, congestion, and inflammatory cell
infiltration that decreased markedly in the coadministration of hesperidin
with the TiO2NP group. Conclusion: Hesperidin
cotreatment offers significant protection against TiO2NP-induced
oxidative stress and biochemical and histological alteration in the
brain.